Welcome to our dedicated page for CHEVRON SEC filings (Ticker: CVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CHEVRON's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CHEVRON's regulatory disclosures and financial reporting.
Chevron Chief Legal Officer R. Hewitt Pate reported option exercises and related share sales in a pre-planned transaction. He exercised vested non-qualified stock options on February 27, 2026 and March 2, 2026, converting them into Chevron common stock.
On those dates, he then sold a total of 93,475 common shares in multiple open-market trades under a Rule 10b5-1 trading plan adopted on November 26, 2025, at weighted-average prices within ranges from $183.90 to $190.62 per share. After these transactions, he directly owned 8,558 Chevron shares, with additional indirect holdings through a 401(k) plan and family trusts, including a spouse’s trust for which he disclaims beneficial ownership.
Chevron Corporation’s Chief Financial Officer Eimear P. Bonner reported a series of option exercises and related share sales. She exercised non-qualified stock options into 45,800 shares of common stock on February 27 and March 2, 2026, then sold 45,800 shares in open-market transactions.
The sales, at weighted-average prices generally in the mid-$180s to about $190.60 per share, were carried out under a Rule 10b5-1 trading plan adopted on November 22, 2025. After these transactions, she directly owned 8,427 Chevron shares and indirectly held 408 shares through a share incentive plan.
Chevron Corp executive Jeff B. Gustavson, President, New Energies, reported a same‑day option exercise and share sale. On February 27, 2026, he exercised a non‑qualified stock option for 6,667 shares, converting it into common stock at a stated exercise price of $125.35 per share. He then sold 6,667 shares of common stock at an average price of $186.0394 per share, an open‑market transaction. After these trades, his directly held common stock position was reported as 3,716 shares, with an additional 3 shares held indirectly through a 401(k) plan. A footnote states that he disclaims beneficial ownership of 4,633 shares underlying the remaining option securities.
CVX reports insider transactions including a 10b5-1 sale by Michael K. Wirth of 320,700 common shares on 01/05/2026 for $52,271,983.38.
The filing also shows exercises of stock options for issuance to the issuer of 182,100 and 90,524 common shares on 03/02/2026, paid in cash.
Form 144 notice: 17,400 shares of Common stock are listed for proposed sale, shown as resulting from an exercise of stock options on 03/02/2026 with cash as the payment method.
The excerpt also lists recent 10b5-1 sales by Eimear Bonner: 28,400 shares on 02/27/2026 for $5,284,075.60; 32,100 shares on 01/30/2026 for $5,617,731.12; 7,534 shares on 01/28/2026 for $1,280,780.00; and 28,334 shares on 01/05/2026 for $4,676,526.70.
Chevron insider submitted a Form 144 notice to sell 182,100 common shares on 03/02/2026 arising from the exercise of stock options and intended to be sold for cash.
The filing also records 320,700 shares sold under a 10b5-1 plan on 01/05/2026, generating $52,271,983.38.
CVX filing reports Rule 144/Section sales and an exercise transaction by an associated holder. The notice lists a 58,000 share transaction tied to an exercise of stock options on 03/02/2026. The excerpt also lists prior 10b5-1 sales of 35,475 shares on 02/27/2026 for $6,600,563.64 and 41,134 shares on 01/30/2026 for $7,256,037.60.
Form 144 filing reports proposed sales of common stock. The filing lists 139,600 shares offered for sale on 03/02/2026, shown as two lots of 62,600 and 77,000 shares associated with Morgan Stanley Smith Barney LLC. The filing also records a prior sale of 45,800 shares by Mark A Nelson on 02/02/2026 with an indicated value of 7,976,843.88.
Andrew B. Walz reported proposed sales of common stock under Form 144. The filing lists exercises of options under a registered plan on 03/02/2026 showing 5,000 and 6,600 shares tied to cash exercises. The filing also discloses prior open-market sales by Mr. Walz of 1,463 shares on 02/18/2026 for $268,949.87, 666 shares on 02/12/2026 for $122,144.40, and 22,200 shares on 02/03/2026 for $3,919,050.36.
R HEWITT PATE reported insider transactions involving common stock: a 10b5-1 sale of 41,134 shares on 01/30/2026 generating $7,256,037.60, and an exercise of 35,475 stock options on 02/27/2026 settled for cash totaling $6,533,076.00.
The transactions are recorded on a Form 144 and list broker information. The 10b5-1 sale and the option exercise are separate actions with their respective dates and cash amounts as shown above.